USE OF NOVEL HEALTH-RELATED QUALITY OF LIFE MEASURES TO ASSESS THE EFFECT OF METAMORPHOPSIA SYMPTOMS IN PATIENTS WITH VITREOMACULAR TRACTION, WITH OR WITHOUT MACULAR HOLE- THE MEMO STUDY
Author(s)
Lescrauwaet B1, Brazier J2, Aly A3, Hirneiß C4, Patel P5
1Xintera Ltd, Cambridge, UK, 2University of Sheffield, Sheffield, UK, 3Pharmerit International, Bethesda, MD, USA, 4Ludwig Maximilians University München, München, Germany, 5NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK
OBJECTIVES: The National Institute for Health and Care Excellence recommends the use of generic preference-based measures of health for its Health Technology Assessments. However, these data may not be appropriate for all health conditions. We report predictive outcomes for utility scores (US) using alternative health preference estimation methods in vitreomacular tration (VMT), and for eye conditions such as metamorphopsia.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PSS52
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities
Disease
Sensory System Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now